Clinical Study

Bio-Data-16-01 Using Novel Objective Bio-Data To Improve Quality Of Life Assessment In Patients Undergoing Cytotoxic Chemotherapy: An Interventional Pilot Study

Posted Date: Jun 11, 2019

  • Investigator: Thomas Herzog
  • Specialties: Breast Cancer, Cancer, Gynecologic Oncology, Lung Cancer, Oncology, Ovarian Cancer
  • Type of Study: Device

The goal of this study is to capture on-treatment objective quantification of physical activity/ bio-data (steps, calories, standing time) and sleep patterns and cycles in patients receiving chemotherapy front-line for breast, lung, and ovarian cancer, and to record the impact of therapy on quality of life.

Criteria:

To Be Eligible: Must Be A Female With Breast, Lung, Ovarian, Fallopian Tube, Or Primary Peritoneal Cancer. Ecog Performance Of 0,1, Or 2, Patients Who Will Undergo At Least 3 Cycles Of Chemotherapy.

Keywords:

Breast Cancer, Ovarian Cancer, Lung Cancer

For More Information:

Uc Cancer Center
513-584-7698
cancer@uchealth.com